ReviewFrontiers in neurology2023

The impact of disease modifying therapies on cognitive functions typically impaired in multiple sclerosis patients: a clinician's review.

Karolina Kania et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.